Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Preparing For New 'Combination Product Agreement Meetings'

Oct 22 2018

• By Derrick Gingery

FDAEntrance_1200x675

Related Content

For Combination Product Development, Industry Says Talk Is Cheap

Jan 28 2013

Combo-Product Sponsors Could More Easily Get Device Designation At US FDA

Jul 29 2018

FDA Approving Complex Generics Pre-ANDA Meeting Requests At Higher Rates

Sep 22 2018

FDA’s Special Protocol Rescissions Get U.S. Capitol, Venture Capital Attention

Jun 13 2014

Combo Product Review Pilot At US FDA Will Offer All Applications Intercenter Consults

Dec 21 2016

US FDA Special Protocol Assessment Draft Guidance Adds Biosimilars But Not Much Clarity

May 10 2016

Pre-ANDA Meetings Proving Tough To Get – Nearly Half Of Requests Denied

May 25 2018

Additional Topics

United States Regulation FDA Legislation Combination Products BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window